A monoclonal antibody being studied in the treatment of certain types of cancer. MDX-010 is made in the laboratory and binds to the molecule CTLA-4 on T cells (a type of white blood cell). MDX-010 may block CTLA-4 and help the immune system kill cancer cells. Also called ipilimumab.
Leave a Comment